XRHealth

Overview
Activities
News
Extended Reality?
Telehealth?
Mental Health Tech?
Product stageSegments
Early
?
AR/VR platforms
?

XRHealth operates virtual clinics by leveraging proprietary CE registered XR technology that is FDA approved. The platform also integrates licensed clinicians and advanced data analytics to provide remote patient monitoring (RPM) solutions. Advanced data analytics provide real-time data that can be used by clinicians to adjust training plans on the fly by monitoring patients’ VR sessions on the platform. The company’s on-demand remote virtual care solutions provide drug-free, personalized therapies. This includes real and virtual environments, games, and exercises that focus on physical therapy, behavioral health (stress, anger, depression), pain management, and memory and cognitive training. In June 2023, the company received a US patent for closed loop biofeedback, with the company’s tech being used to combine the Apple Watch with Apple’s Vision Pro headset.

The XRHealth package includes a VR headset, video calls, access to its mobile app (where users can communicate with an XRHealth therapist and track progress), personalized plan-of-care, and consistent updates based on the patient's progress. XRHealth sells directly to consumers through three out-of-pocket subscription-based pricing plans starting at ~USD 70 per week. It also partnered with insurance companies to cater to businesses and covered more than 50 million people as of February 2022. In April 2023 , the company announced its intention to merge with Amelia VR, subject to shareholder approval, amongst other conditions.

Funding and financials

The company's most recent funding round was in January 2024, where it raised USD 6 million in a round led by Asabys Partners. Funds were earmarked to bolster platform capabilities, focus on R&D, invest in partnerships with healthcare organizations and improve marketing efforts.

HQ location:
200 Highland Ave Suite 202 Needham MA USA
Founded year:
2016
Employees:
101-250
IPO status:
Private
Total funding:
USD 40.8 mn
Last Funding:
USD 6.0 mn (Series Unknown; Jan 2024)
Last valuation:
USD 81.0 mn (Feb 2022)
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

EDGE Insights

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.